Ocugen Inc
For the period ended Dec 31, 2023. Filed Apr 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 16, 2024
OCGN$0.97+5.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Financial Statements F-
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |||
| Report of Independent Registered Public Accounting Firm | F-2 | ||
|---|---|---|---|
| Consolidated Financial Statements | |||
| Consolidated Balance Sheets at December 31, 2023 and 2022 | F-4 | ||
| Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2023 and 2022 | F-5 | ||
| Consolidated Statements of Stockholders' Equity for the years ended December 31, 2023 and 2022 | F-6 | ||
| Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 | F-7 | ||
| Notes to the Consolidated Financial Statements | F-9 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.